id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-P-1457-0031,FDA,FDA-2022-P-1457,Letter from FDA CFSAN to American Olive Oil Producers Association,Other,Letter(s),2023-05-09T04:00:00Z,2023,5,2023-05-09T04:00:00Z,,2023-05-09T19:43:38Z,,0,0,09000064859e8faf
FDA-2022-P-1457-0029,FDA,FDA-2022-P-1457,Letter from FDA CFSAN to Deoleo,Other,Letter(s),2023-05-09T04:00:00Z,2023,5,2023-05-09T04:00:00Z,,2023-05-09T19:43:21Z,,0,0,09000064859e8fad
FDA-2022-P-1457-0030,FDA,FDA-2022-P-1457,Letter from FDA CFSAN to North American Olive Oil Association,Other,Letter(s),2023-05-09T04:00:00Z,2023,5,2023-05-09T04:00:00Z,,2023-05-09T19:43:29Z,,0,0,09000064859e9889
FDA-2022-P-1457-0027,FDA,FDA-2022-P-1457,180 Day Interim Response Letter from FDA CFSAN to North American Olive Oil Association,Other,,2023-01-03T00:00:00Z,2023,1,,,2025-02-07T16:00:29Z,,0,1,090000648557eac4
FDA-2022-P-1457-0026,FDA,FDA-2022-P-1457,180 Day Interim Response Letter from FDA CFSAN to North American Olive Oil Association,Other,,2023-01-03T00:00:00Z,2023,1,,,2025-02-07T16:00:11Z,,0,1,090000648557eac0
FDA-2022-P-1457-0028,FDA,FDA-2022-P-1457,180 Day Interim Response Letter from FDA CFSAN to North American Olive Oil Association,Other,,2023-01-03T00:00:00Z,2023,1,,,2025-02-07T16:00:48Z,,0,1,090000648557ebc4